Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Outstanding (Diluted Average) (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $43.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 14.31% to $43.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $43.0 million, a 14.31% increase, with the full-year FY2024 number at $36.8 million, up 10.82% from a year prior.
  • Shares Outstanding (Diluted Average) was $43.0 million for Q3 2025 at Orchestra BioMed Holdings, up from $38.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $43.0 million in Q3 2025 to a low of $9.2 million in Q1 2022.
  • A 4-year average of $29.4 million and a median of $35.2 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 208.03% in 2023, then grew 6.75% in 2024.
  • Orchestra BioMed Holdings' Shares Outstanding (Diluted Average) stood at $15.0 million in 2022, then skyrocketed by 121.67% to $33.2 million in 2023, then increased by 10.82% to $36.8 million in 2024, then increased by 16.8% to $43.0 million in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Shares Outstanding (Diluted Average) are $43.0 million (Q3 2025), $38.4 million (Q2 2025), and $38.2 million (Q1 2025).